SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Costantino who wrote (1098)7/9/1997 2:38:00 PM
From: I. Luttichuys   of 1762
 
Hello Rick, I agree that approval for C2B8 is quite likely. I would bank on it.
I agree with Billkirn that there is the potential for a sell-off on the news. I believe even AGPH did this although, your point is well taken about hype and one could certainly argue that AGPH falls in that category.
You do know that IDPH is notoriously volatile and a drop from 30 to 20 is something we've seen more than once.
I am no longer an IDPH shareholder but, I just wanted to make the point that my intention was always to sell before the FDA decision was announced but, as you point out, I don't think much of the hype element is here and, if we stay at these levels or lower up into approval, perhaps we will rise on the news.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext